Trial Details
COMPLETEDBasic Information
| Clinical ID | c2503 |
|---|---|
| Identifier | NCT03395184 |
| Trial Title | Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF-06700841 In Subjects With Moderate To Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: PF-06651600 Placebo|DRUG: PF-06651600|DRUG: Placebo PF-06700841|DRUG: PF-06700841 |
Participant Information
| Sponsor | Pfizer |
|---|---|
| City | Dothan |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2018-02-02 |
|---|---|
| Primary Completion Date | 2023-10-19 |
| Completion Date | 2023-10-19 |